Barbara Davis Center

Running trials

• Recruiting

  Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative

  NCT07720388· Source

• Recruiting

  Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

  NCT07216391· Phase 2· Source

• Recruiting

  App-Based Certified Diabetes Education Therapy (AB-CDE)

  NCT07282639· Source

• Recruiting

  Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes

  NCT06618027· Source

• Recruiting

  Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop Systems

  NCT06575790· Source

• Recruiting

  Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes

  NCT06575842· Source

• Active, not recruiting

  Fully Closed Loop At Home (FCL@Home)

  NCT06041971· Source

• Active, not recruiting

  TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

  NCT05594563· Phase 2· Source

• Active, not recruiting

  A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

  NCT03811561· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 1 diabetes6 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

  NCT06273124· Source

• Completed

  INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

  NCT05904743· Phase 4· Source

• Completed

  Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

  NCT05683392· Source

• Completed

  Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

  NCT05325294· Source

• Completed

  Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

  NCT06177691· Source

• Terminated

  IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)

  NCT04524949· Phase 2· Source